Literature DB >> 26953657

Prenatal and Perinatal Determinants of Lung Health and Disease in Early Life: A National Heart, Lung, and Blood Institute Workshop Report.

Tracy A Manuck1, Philip T Levy2, Cynthia Gyamfi-Bannerman3, Alan H Jobe4, Carol J Blaisdell5.   

Abstract

Human lung growth and development begins with preconception exposures and continues through conception and childhood into early adulthood. Numerous environmental exposures (both positive and negative) can affect lung health and disease throughout life. Infant lung health correlates with adult lung function, but significant knowledge gaps exist regarding the influence of preconception, perinatal, and postnatal exposures on general lung health throughout life. On October 1 and 2, 2015, the National Heart, Lung, and Blood Institute convened a group of extramural investigators to develop their recommendations for the direction(s) for future research in prenatal and perinatal determinants of lung health and disease in early life and to identify opportunities for scientific advancement. They identified that future investigations will need not only to examine abnormal lung development, but also to use developing technology and resources to better define normal and/or enhanced lung health. Birth cohort studies offer key opportunities to capture the important influence of preconception and obstetric risk factors on lung health, development, and disease. These studies should include well-characterized obstetrical data and comprehensive plans for prospective follow-up. The importance of continued basic science, translational, and animal studies for providing mechanisms to explain causality using new methods cannot be overemphasized. Multidisciplinary approaches involving obstetricians, neonatologists, pediatric and adult pulmonologists, and basic scientists should be encouraged to design and conduct comprehensive and impactful research on the early stages of normal and abnormal human lung growth that influence adult outcome.

Entities:  

Mesh:

Year:  2016        PMID: 26953657     DOI: 10.1001/jamapediatrics.2015.4577

Source DB:  PubMed          Journal:  JAMA Pediatr        ISSN: 2168-6203            Impact factor:   16.193


  24 in total

1.  Neonatal outcome of small for gestational age preterm infants.

Authors:  Stefano Nobile; Paolo Marchionni; Virgilio P Carnielli
Journal:  Eur J Pediatr       Date:  2017-06-28       Impact factor: 3.183

Review 2.  Can We Prevent Bronchopulmonary Dysplasia?

Authors:  Judy L Aschner; Eduardo H Bancalari; Cindy T McEvoy
Journal:  J Pediatr       Date:  2017-10       Impact factor: 4.406

3.  Anti-Vascular Endothelial Growth Factor Antagonists: A Potential Primary Prevention for Bronchopulmonary Dysplasia?

Authors:  Cindy T McEvoy; Manuel Durand
Journal:  Am J Respir Crit Care Med       Date:  2018-03-15       Impact factor: 21.405

4.  Antenatal Determinants of Bronchopulmonary Dysplasia and Late Respiratory Disease in Preterm Infants.

Authors:  Lindsey A Morrow; Brandie D Wagner; David A Ingram; Brenda B Poindexter; Kurt Schibler; C Michael Cotten; John Dagle; Marci K Sontag; Peter M Mourani; Steven H Abman
Journal:  Am J Respir Crit Care Med       Date:  2017-08-01       Impact factor: 21.405

5.  Oral Vitamin C (500 mg/d) to Pregnant Smokers Improves Infant Airway Function at 3 Months (VCSIP). A Randomized Trial.

Authors:  Cindy T McEvoy; Lyndsey E Shorey-Kendrick; Kristin Milner; Diane Schilling; Christina Tiller; Brittany Vuylsteke; Ashley Scherman; Keith Jackson; David M Haas; Julia Harris; Robert Schuff; Byung S Park; Annette Vu; Dale F Kraemer; Julie Mitchell; Jill Metz; David Gonzales; Carol Bunten; Eliot R Spindel; Robert S Tepper; Cynthia D Morris
Journal:  Am J Respir Crit Care Med       Date:  2019-05-01       Impact factor: 21.405

6.  Anti-sFlt-1 Therapy Preserves Lung Alveolar and Vascular Growth in Antenatal Models of Bronchopulmonary Dysplasia.

Authors:  Bradley Wallace; Amelie Peisl; Gregory Seedorf; Taylor Nowlin; Christina Kim; Jennifer Bosco; Jon Kenniston; Dennis Keefe; Steven H Abman
Journal:  Am J Respir Crit Care Med       Date:  2018-03-15       Impact factor: 21.405

7.  Early Pulmonary Vascular Disease in Preterm Infants Is Associated with Late Respiratory Outcomes in Childhood.

Authors:  Peter M Mourani; Erica W Mandell; Maxene Meier; Adel Younoszai; John T Brinton; Brandie D Wagner; Sanne Arjaans; Brenda B Poindexter; Steven H Abman
Journal:  Am J Respir Crit Care Med       Date:  2019-04-15       Impact factor: 21.405

Review 8.  Recent advances in antenatal factors predisposing to bronchopulmonary dysplasia.

Authors:  Elizabeth Taglauer; Steven H Abman; Roberta L Keller
Journal:  Semin Perinatol       Date:  2018-10-05       Impact factor: 3.300

9.  Perinatal Hypoxia-Inducible Factor Stabilization Preserves Lung Alveolar and Vascular Growth in Experimental Bronchopulmonary Dysplasia.

Authors:  Kellen Hirsch; Elizabeth Taglauer; Gregory Seedorf; Carly Callahan; Erica Mandell; Carl W White; Stella Kourembanas; Steven H Abman
Journal:  Am J Respir Crit Care Med       Date:  2020-10-15       Impact factor: 21.405

10.  Antenatal mesenchymal stromal cell extracellular vesicle treatment preserves lung development in a model of bronchopulmonary dysplasia due to chorioamnionitis.

Authors:  Alison N Abele; Elizabeth S Taglauer; Maricar Almeda; Noah Wilson; Abigail Abikoye; Gregory J Seedorf; S Alex Mitsialis; Stella Kourembanas; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-12-08       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.